Consonance Capital Management LP Harpoon Therapeutics, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$11.01 - $18.52 $9.29 Million - $15.6 Million
-844,162 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$11.11 - $24.72 $9.38 Million - $20.9 Million
844,162 New
844,162 $14 Million

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email